Related by context. All words. (Click for frequent words.) 76 sodium glucose cotransporter 72 reversible inhibitor 71 cathepsin K inhibitor 70 highly selective inhibitor 69 PDE4 inhibitor 69 investigational humanized monoclonal antibody 68 MKC# 68 liposomal formulation 68 insulin sensitizer 68 receptor agonist 68 selective antagonist 67 metaglidasen 67 Dapagliflozin 67 volociximab 67 sodium glucose transporter 67 davalintide 67 MTP inhibitor 66 non thiazolidinedione TZD 66 selective modulator 66 intranasal formulation 66 Saxagliptin 66 SGLT 66 selective inhibitor 66 TNF Tumor Necrosis Factor 66 proteasome inhibitor 66 TRX1 66 Silodosin 66 ADP receptor antagonist 66 inhaled formulation 66 receptor tyrosine kinase inhibitor 66 aurora kinase 66 Panzem R 66 XL# anticancer compounds 66 selective A2A adenosine receptor 65 dipeptidyl peptidase 4 65 microsomal triglyceride transfer 65 PEGylated Fab fragment 65 orally administered inhibitor 65 Balaglitazone 65 selectively inhibiting 65 Granulocyte Colony Stimulating Factor 65 MKC# MT 65 novel histone deacetylase 65 TLR9 agonist 65 partial agonist 65 selective agonist 65 AAG geldanamycin analog 65 SGLT2 65 #HT# 65 IAP inhibitor 65 Mipomersen 65 6R BH4 65 albiglutide 65 lomitapide 65 5 HT3 antagonist 65 topical gel formulation 65 delta gamma agonist 65 Archexin 65 THR beta agonist 65 generation purine nucleoside 65 selective adenosine 65 pioglitazone HCl 65 oral prodrug 65 Hsp# Inhibitor 65 cortisol synthesis 65 PSN# [001] 64 TRO# 64 LymphoStat B belimumab 64 SGLT2 inhibitors 64 Lixivaptan 64 Glucagon Like Peptide 64 IMiDs R 64 2A receptor agonist 64 PSN# [002] 64 protein tyrosine phosphatase 1B 64 somatostatin analogue 64 investigational pharmacologically unique 64 octreotide acetate 64 JAK inhibitor 64 insulin sensitizing 64 norepinephrine reuptake inhibitor 64 PNP inhibitor 64 mertansine 64 humanized anti 64 peripherally acting 64 acyclovir Lauriad R 64 adrenoceptor agonist 64 delta opioid receptor 64 dasatinib Sprycel ® 64 dual PPAR peroxisome 64 Janus kinase 64 small molecule tyrosine 64 generation antisense inhibitor 64 inverse agonist 64 cholesteryl ester transfer 64 Inhalation Powder 64 hypoxia activated prodrug 64 proliferator activated receptor 64 antiarrhythmic 64 Romiplostim 64 glucagon receptor 64 mesylate 64 selective phosphodiesterase 64 small molecule glucokinase 64 YONDELIS 64 converting enzyme 64 PEGylated anti 64 P2Y 64 selective serotonin 2C receptor 64 inhibit oxidative stress 64 aripiprazole Abilify 64 corticosteroid dexamethasone 63 developing Bicifadine serotonin 63 RhuDex ® 63 Aurora Kinase 63 angiogenesis inhibitor 63 Phase 2b clinical trials 63 Xanafide 63 Factor VIIa 63 tumor vascular disrupting 63 CCR9 antagonist 63 Lisofylline 63 mGluR5 negative 63 Angiotensin Converting Enzyme 63 Ganciclovir 63 AKT inhibitor 63 Janus Kinase 63 xanthine oxidase inhibitor 63 MKC# MKC# PP 63 Preclinical studies suggest 63 topoisomerase II inhibitor 63 methylnaltrexone bromide 63 pralatrexate injection folate analogue 63 selective receptor agonist 63 receptor partial agonist 63 anti amnesic 63 mitogen activated ERK kinase 63 HSP# inhibitor 63 receptor inhibitor 63 XP# XP# 63 Naproxcinod 63 receptor antagonist 63 Receptor Antagonists 63 Orally administered 63 insulin sensitizers 63 Recombinant Human 63 Mg Usa 63 oral dihydropyrimidine dehydrogenase DPD 63 5 HT2A receptor 63 2 methoxyestradiol 63 thromboxane A2 63 Sitagliptin 63 basal insulin analogue 63 Tumor necrosis factor 63 SGLT1 63 mu opioid receptor antagonist 63 peripherally restricted 63 Pazopanib 63 selective kinase inhibitor 63 Technosphere ® 63 DNA intercalator 63 orally dosed 63 selective androgen receptor modulator 63 Febuxostat 63 5 HT2A inverse 63 Denufosol 63 TMC# [002] 63 Personalized Immunotherapy 62 Dasatinib 62 antibody MAb 62 PPAR gamma agonist 62 mTOR inhibitor 62 ® pioglitazone HCl 62 adenosine A2A 62 Dabigatran etexilate 62 orally bioavailable 62 AFREZZA TM 62 beta 1a 62 peptibody 62 angiotensin receptor blocker ARB 62 * olmesartan medoxomil 62 PF # [002] 62 Carfilzomib 62 CD# monoclonal antibody 62 TBC# 62 Receptor Antagonist 62 Talabostat 62 DP VPA 62 Vernakalant 62 BLyS specific 62 Methylnaltrexone 62 calcitonin gene related 62 metformin sulfonylureas 62 Phase #b/#a clinical 62 seliciclib CYC# 62 Resten NG 62 acetonide FA 62 mGluR2 positive 62 CIMZIA TM 62 angiotensin II receptor blocker 62 mitotic kinesin 62 dipeptidyl peptidase IV 62 diarrhea predominant irritable 62 CYP#A# CYP#D# 62 ATL/TV# 62 receptor agonists 62 Cytochrome P# 62 antiplatelet agent 62 Ambrisentan 62 opioid receptor antagonist 62 non porcine pancreatic 62 DU #b 62 selective estrogen receptor modulator 62 highly selective endothelin 62 outlicensed 62 oral isotype selective HDAC 62 #beta HSD1 62 HMG CoA reductase inhibitors 62 Blinatumomab 62 rxRNA 62 hyaluronidase enzyme 62 novel VDA molecule 62 Luteinizing Hormone Releasing Hormone 62 reversible inhibitors 62 Elagolix 62 CCX# B 62 small molecule thrombopoietin 62 Vidofludimus 62 therapeutically inactive prodrug 62 dihydrochloride 62 Angiotensin II 62 cyclin dependent kinase inhibitor 62 edifoligide 62 5 HT4 62 GW# [003] 62 TH# [003] 62 adenosine injection 62 oxidative stress inducer 62 AEGR 62 thyroid hormone receptor 62 mTOR mammalian target 62 erlotinib Tarceva ® 62 orally bioavailable mimics 62 Squalamine 62 reslizumab 62 AFRESA ® 62 Aflibercept 62 nilotinib Tasigna 62 small molecule Hedgehog 62 dopamine D2 62 mild vasodilator 62 ATL# [002] 62 vidofludimus 62 selective A1 adenosine 62 INT# [002] 62 Fx #A 62 ENMD # 62 HGS# 61 TELINTRA 61 RH1 61 alpha#beta# integrin 61 sphingosine 1 61 5 lipoxygenase activating 61 humanized interleukin 6 61 oncolytic virus therapies 61 CG# [003] 61 Ocrelizumab 61 anticancer compound 61 receptor antagonists 61 Daclizumab 61 Diamyd R 61 SGLT 2 61 BRILINTA 61 non nucleoside inhibitor 61 Lubiprostone 61 Vicriviroc 61 CYT# potent vascular disrupting 61 somatostatin analog 61 antibody MT# 61 Maribavir 61 atacicept 61 Irinotecan 61 anti angiogenic agent 61 factor VIIa 61 mediated inhibition 61 MEK inhibitor 61 PHX# 61 Troxatyl 61 Elvitegravir 61 vesicular monoamine transporter 61 Bucindolol 61 vascular disrupting agent 61 targeted antifolate 61 candidate deforolimus 61 imatinib Gleevec ® 61 Symadex 61 D aspartate NMDA receptor 61 Elesclomol 61 Telmisartan 61 Pertuzumab 61 Aptivus ® 61 potent inhibitor 61 glucokinase activator 61 receptor modulators 61 mGluR2 NAM 61 PEGylated interferon 61 Zoraxel TM 61 oral salmon calcitonin 61 Pimavanserin 61 ATL# [001] 61 Belimumab 61 DEB# 61 CDP# 61 antiangiogenic agent 61 rivastigmine Exelon 61 Omacetaxine 61 5 HT6 receptor 61 BAY #-# 61 selective androgen receptor modulators 61 bucindolol hydrochloride 61 Albugon 61 interleukin IL -# 61 JAK3 inhibitor 61 Initiates Enrollment 61 PDX pralatrexate 61 targeted radiotherapeutic 61 coronary vasodilation 61 injectable formulation 61 CTAP# Capsules 61 histone deacetylase HDAC inhibitor 61 Begins Dosing 61 immunotherapeutic agent 61 hyperphenylalaninemia HPA due 61 Receptor Agonist 61 plasmid encoding 61 prostanoid 61 neuropathic pain metabolic diseases 61 TLK# 61 Maxy G# 61 LAF# 61 Atrasentan 61 peptidic compound 61 proteasome inhibitors 61 activin receptor type 61 inhibitor PPI 61 muraglitazar 61 JAK2 inhibitor 61 Crofelemer budesonide foam 61 PRT# 61 peptide CGRP 61 IMiDs ® 61 SURFAXIN r 61 HCV RNA polymerase 61 NK1 61 HepDirect prodrug 61 Liposomal 61 intravenously administered 61 HQK 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 administered subcutaneously 61 MAGE A3 ASCI 61 GLP1 61 5 HT4 receptor 61 Tanespimycin 61 nucleoside analog 61 VEGFR2 inhibitor 61 eprotirome 61 Intravitreal 61 PI3K/Akt pathway inhibitor 61 Tezampanel 61 E2F Decoy 61 ISTODAX 61 Cetuximab Erbitux 61 1beta 61 selectively inhibited 61 DPP4 inhibitor 61 Bicifadine 61 NMDA antagonist 61 humanized monoclonal 61 rusalatide acetate 61 5 HT2A serotonin 61 HuMax TAC 61 oral rivaroxaban 61 antisense oligonucleotide 61 Tubulin 61 signal transduction inhibitor 61 Alfacell proprietary ribonuclease 61 HCD# [002] 61 virus HCV protease inhibitor 61 sunitinib Sutent ® 61 visilizumab 61 direct thrombin inhibitor 61 Tyrima 61 Initiates Clinical 61 Mycophenolate Mofetil 61 taxane derivative 61 5 HT3 receptor 61 tyrosine kinase inhibitor 60 RAF kinase 60 sapacitabine CYC# 60 receptor modulator 60 oral proteasome inhibitor 60 alpha 2A 60 Valtropin 60 oral nucleoside analogue 60 5HT 60 selective inhibition 60 HCV NS5B polymerase 60 Azacitidine 60 JAK1 60 maleate 60 Factor Xa inhibitor 60 Aplidin 60 R#/MEM # 60 SinuNase TM 60 GLP1 INT TM 60 oral ghrelin agonist 60 vanilloid receptor 60 P#Y# [002] 60 ELND-#/AZD-# 60 Tofacitinib 60 Avanafil 60 IMiD 60 vinca alkaloid 60 refractory chronic lymphocytic 60 potently inhibit 60 Randomized Phase 60 selective immunoproteasome inhibitor 60 drug pipeline TAFA# 60 N acetylgalactosamine 60 Locteron ® 60 RhuDex 60 novel synthetic peptide 60 pan histone deacetylase 60 adrenergic receptor agonist 60 targeting CD# 60 Pegloticase 60 glycogen synthase kinase 60 Muraglitazar 60 Cyclooxygenase 60 prescribed proton pump 60 Tyrosine Kinase Inhibitor 60 class mGluR5 inhibitor 60 Enkephalin 60 poly ADP ribose polymerase 60 serotonin norepinephrine reuptake inhibitor 60 5 HT2A 60 factor Xa 60 sitagliptin metformin 60 cardiac contractility 60 M1 muscarinic 60 Rivaroxaban 60 Cathepsin S 60 Initiate Phase 60 Thiarabine 60 BAL# [002] 60 R sorafenib tablets 60 Traficet EN 60 receptor blocker 60 dihydrofolate reductase 60 BCR ABL inhibitor 60 BN# [004] 60 delta isoform 60 PPAR peroxisome proliferator activated 60 angiotensin II receptor 60 Interferon gamma 60 apoptosis proteins 60 elotuzumab 60 HepeX B TM 60 Completes Patient Enrollment 60 Angiotensin 60 chimeric monoclonal antibody 60 Temsirolimus 60 mediated apoptosis 60 CRTH2 60 microtubule inhibitor 60 selectively binds 60 Kamada AAT 60 nilotinib Tasigna ® 60 folate analogue metabolic 60 IMA# 60 PRN FDA Approves 60 Serostim ® 60 Simulect 60 incretin mimetic 60 Fc fusion protein 60 vapreotide acetate 60 biased ligand 60 Linaclotide 60 c Raf kinase 60 Carvedilol 60 non nucleoside 60 Meets Primary Endpoint 60 Spiegelmer ® 60 multi kinase inhibitor 60 JAK2 Inhibitor 60 intravenous AAT 60 IgG1 monoclonal antibody 60 coadministration 60 palonosetron 60 prucalopride 60 Anticalin R 60 CYC# 60 Bosutinib 60 Cetrorelix 60 2 inhibitor CYT# 60 brivanib 60 QNEXA 60 TRV# [001] 60 romazarit 60 thiazolidinediones TZDs 60 Initiates Phase II 60 Leuprolide 60 triggers apoptosis programmed 60 Safinamide 60 oral dual endothelin 60 NV1FGF 60 oral picoplatin 60 VEGF inhibitors 60 MEK inhibitors 60 mineralocorticoid receptor 60 5 HT6 60 Tumour Vascular Disrupting Agent 60 Annamycin 60 JZP 60 P#X# antagonist 60 Anidulafungin 60 BCR ABL inhibitors 60 sulfonylhydrazine class 60 GSK '# 60 Enzastaurin 60 Pruvel TM 60 epothilones 60 monocyte chemotactic protein 60 Losartan 60 Mg Uk 60 muscarinic 60 humanized monoclonal antibody 60 KSP inhibitor 60 ALS #-# 60 teriflunomide 60 Genasense ® oblimersen 60 Perifosine 60 Vidaza azacitidine 60 Tasimelteon 60 oral Janus kinase 60 Sudhir Agrawal D.Phil 60 Ceflatonin R 60 Imatinib mesylate 60 sublingual tablet formulation 60 nucleotide analog 60 compound PMX # 60 nalbuphine ER 60 DB# [003] 60 phase IIb clinical 60 lamotrigine Lamictal 60 investigational oral 60 pan HDAC inhibitor 60 VAPRISOL 60 rasagiline tablets 60 Lisofylline LSF 60 polysaccharide polymer 60 otelixizumab 60 oral antidiabetic medication 60 deforolimus 60 novel peptide 60 regorafenib 60 either acutely decompensated 60 Romidepsin 60 riociguat 60 luteinizing hormone releasing 60 Prodarsan R 60 anti secretory 60 NOX E# 60 HuLuc# 60 Lenalidomide 60 AEG# 60 memantine HCl 60 Ticagrelor 59 Cleviprex TM clevidipine 59 modulator SERM 59 Epratuzumab 59 bile acid sequestrant 59 GPR# agonist 59 Microplasmin 59 selectively inhibits 59 long acting muscarinic 59 opioid induced bowel dysfunction 59 entacapone 59 PPARγ 59 miconazole Lauriad R 59 Unit Dose Budesonide 59 QRX 59 kidney urologic 59 adalimumab Humira 59 SUTENT ® 59 cyclin dependent kinase CDK 59 negative allosteric modulator 59 anthracycline derivative 59 directed radiotherapeutic antibody 59 RANK Ligand 59 compound KOS 59 INCB# [003] 59 N methyl 59 BCG refractory 59 MOVIPREP R 59 allosteric modulator NAM 59 DGAT 59 histamine dihydrochloride 59 oral renin inhibitor 59 Iluvien ® 59 Vidaza R 59 FOLOTYN ® 59 NU# direct 59 leading oral taxane 59 CU NP 59 Files IND 59 Pharmacokinetics PK 59 stable nucleic acid 59 including eniluracil ADH 59 agonistic human 59 Kinase Inhibitor 59 cleavable linker 59 polymerase inhibitor 59 selective estrogen receptor 59 Elacytarabine 59 CD4 monoclonal antibody 59 mediated phosphorylation 59 Desmoteplase 59 Solulin 59 therapeutic monoclonal antibody 59 Delta opioid receptor 59 Topoisomerase II 59 thalidomide Thalomid 59 receptor inhibiting monoclonal 59 TRANSDUR ® 59 receptor antagonism 59 thrombopoietin TPO natural 59 CYP #A# 59 immune modulatory 59 cetuximab Erbitux R 59 SinuNase ™ 59 matrix metalloproteases 59 vascular inflammation 59 Kuvan R 59 candesartan cilexetil 59 midstage clinical 59 radiolabeled 59 Eltrombopag 59 huC# DM4 59 HCV protease inhibitors 59 GAD# 59 SAR# [002] 59 markets HP Acthar 59 pancreatic alpha 59 radiation sensitizer 59 product candidate Lpathomab 59 Receives Orphan Drug Designation 59 candidate AQ4N 59 sapropterin dihydrochloride 59 M# rationally 59 potent topoisomerase II 59 Calcitonin 59 lintuzumab SGN 59 E1 INT TM 59 Monopril 59 LymphoStat B TM 59 chronic eosinophilic leukemia 59 alagebrium 59 Xelox 59 BrachySil TM 59 Factor Receptor 59 histone deacetylase inhibitor 59 developing Zerenex ferric 59 Starlix 59 gamma secretase inhibitor 59 novel oral anticoagulant 59 Atripla combines 59 CB2 selective receptor agonist 59 CORT # 59 JAK inhibitors 59 potent antiproliferative 59 Boceprevir 59 Lixisenatide 59 Chemokine Receptor 59 mTOR kinase 59 delivers fluocinolone acetonide FA 59 E selectin 59 #D#C# 59 docetaxel Taxotere ® 59 fosbretabulin 59 regulated kinase 59 Drug Candidate 59 Oral NKTR 59 antidiabetic 59 Interferon beta 59 insulin aspart 59 novel synthetic PEGylated 59 tramiprosate Alzhemed TM 59 ALGRX 59 TLR8 agonist 59 gets USFDA nod 59 ocular formulation 59 SPRYCEL ® 59 HIV integrase inhibitor 59 3TC lamivudine 59 novel emulsion formulation 59 potential vanilloid 59 multicenter Phase II 59 potent CYP#A# inhibitors 59 sorafenib tablets 59 sunitinib malate 59 Biolimus A9 59 potent anticancer 59 Bevirimat 59 Initiates Phase III 59 adecatumumab MT# 59 Amrubicin 59 Hexvix ® 59 Aviptadil 59 delivery polymer matrix 59 FK# 59 Presents Preclinical Data 59 Alfimeprase 59 photoprotective drug 59 bispecific 59 acyclovir Lauriad ® 59 defensin mimetic antibiotic 59 GTC recombinant form 59 anaphase promoting complex 59 Ostarine 59 triggers apoptosis 59 molecular imaging radiopharmaceutical 59 certain protein tyrosine 59 lanreotide 59 label Lipofen R 59 FBPase 59 Interferon alpha 59 ARIKACE ™ 59 ulimorelin 59 selective inverse agonist 59 methionine aminopeptidase 59 leukotriene pathway 59 Tesetaxel 59 Aliskiren 59 investigational compound 59 Exherin 59 ISIS # 59 direct thrombin inhibitors 59 PDE4 59 NS5B polymerase 59 neuroprotectant 59 laropiprant 59 potently inhibits 59 Melphalan 59 angiotensin receptor 59 apricitabine ATC 59 tiapamil 59 reverse transcriptase inhibitors 59 histone deacetylase HDAC inhibitors 59 Pruvel ™ 59 alvespimycin 59 NS5b 59 humanised antibody 59 Pivotal Phase 59 fibrotic disease 59 GATTEX TM 59 AFREZZA ® 59 Long acting beta2 59 Nifedipine 59 vascular disrupting agents 59 TAFA# 59 agonist LABA 59 SRT# [003] 59 irreversible inhibitor 59 Prodrug 59 forodesine 59 inflammatory PDE 59 cMET 59 Degarelix 59 potently inhibited 59 TREDAPTIVE 59 inhibits protein synthesis 59 DG# compounds targeting 59 cyclic peptide 59 faropenem medoxomil 59 castrate resistant prostate cancer 59 Abbokinase 59 AERx R 59 Novel Oral 59 retaspimycin hydrochloride 59 XYOTAX TM 59 sitaxsentan 59 lumiliximab 59 Omalizumab 59 Phosphodiesterase 59 NXL# 59 prodrugs 59 TO AVOID PREGNANCY WHILE 59 alkylating agent 59 5alpha reductase 58 HuMax EGFr 58 esomeprazole Nexium 58 Teriflunomide 58 antifibrotic 58 dasatinib Sprycel 58 multikinase inhibitor 58 leukotrienes 58 histone deacetylase HDAC 58 accumulate preferentially 58 Phase Ib clinical trials 58 PI3 Kinase 58 DG# [001] 58 Pathway Inhibitor 58 evaluating tivozanib 58 dimebon latrepirdine 58 cytotoxic conjugate 58 Myolimus 58 trodusquemine 58 PKC inhibitor 58 Nexavar sorafenib 58 RoACTEMRA 58 R bisoprolol Euthyrox 58 vinorelbine tartrate 58 sitagliptin phosphate 58 neuroprotective properties 58 inhibit COX 58 zaleplon 58 GV# [001] 58 Dalbavancin 58 isoform selective 58 GVAX ® 58 Prestara 58 Exherin TM 58 Nexavar ® 58 peroxisome proliferator activated 58 Procoralan 58 GMX# 58 Bortezomib 58 Fondaparinux 58 LHRH antagonists 58 familial amyloidotic polyneuropathy FAP 58 staphylococcal vaccine 58 CCR5 antagonist 58 antiangiogenic 58 Secretase 58 octreotide implant 58 oral anticancer 58 novel prodrug 58 potent suppressor 58 demonstrated antitumor activity 58 compound ISA# 58 IMiDs ® compound 58 methyl CpG binding 58 Darusentan 58 Genz # 58 DNA demethylating agent 58 immunomodulatory therapy 58 Desvenlafaxine 58 RAS MAPK pathway 58 Xcytrin R 58 kinase inhibitor 58 azilsartan medoxomil 58 administered intranasally 58 TRIOLEX ™ 58 PPAR gamma agonists 58 Everolimus 58 dyskinesia PD LID 58 receptor CXCR4 58 highly selective adenosine 58 evaluating picoplatin 58 ACOMPLIA R 58 ELADUR TM 58 Medoxomil 58 RTP #i 58 sorafenib tablets small 58 brand ciclesonide HFA 58 Fulvestrant 58 Diamyd ® 58 Rigel R# 58 Achieves Primary Endpoint 58 erlotinib Tarceva 58 binds selectively 58 Nippon Shinyaku 58 antimitotic 58 receptor blockers 58 ADAMTS# 58 6 sulfatase 58 phosphatidylinositol 3 58 immunomodulating 58 Ecallantide 58 Pitavastatin 58 sargramostim 58 Angiotensin converting enzyme 58 tipifarnib 58 Yondelis ® 58 Panzem NCD 58 Vilazodone 58 panitumumab Vectibix 58 Granted Orphan Drug 58 terlipressin 58 acetylcholinesterase 58 XL# XL# 58 metabotropic glutamate receptor 58 serotonin reuptake 58 selective orally bioavailable 58 Indomethacin 58 irbesartan 58 acetylcholine receptor 58 immunotoxin 58 Rheoscience 58 Anavex #-# 58 IV bolus formulation 58 phase IIa clinical 58 Curaxin CBLC# 58 valopicitabine NM# 58 Dynepo TM 58 TRIOLEX HE# APOPTONE HE# 58 CCR2 58 STEDESA 58 #HT#A 58 Liraglutide 58 Zalypsis 58 factor Xa inhibitor 58 Roflumilast 58 Initiates Clinical Trial 58 oral talactoferrin 58 Aurora kinase inhibitor 58 EGFR HER2 58 Protein Kinase C 58 Vascugel 58 platelet inhibitor 58 mecamylamine 58 humanized therapeutic 58 DIFICID ™ 58 EOquin TM phase 58 ZOLINZA 58 Topiramate 58 receptor PPAR 58 Kosan dependence 58 AZILECT R 58 Successfully Completes Phase 58 pro angiogenic 58 Dual Opioid 58 endothelin receptor antagonists 58 controlled multicenter Phase 58 VA# [002] 58 mTOR inhibitors 58 proprietary polysaccharide 58 isoenzyme 58 synthetic lipoglycopeptide antibiotic 58 dutogliptin 58 Pancreate 58 Tolvaptan 58 systemic juvenile idiopathic 58 1α 58 prokinetic agent 58 VEGF receptor 58 immune modulating 58 sorafenib Nexavar 58 Edarbi 58 Marqibo TM 58 TLR7 agonist 58 Panzem ® 58 inhibitor COX 58 investigational monoclonal antibody 58 Sphingosine 1 58 EndoTAG TM -1 58 IAP inhibitors 58 ALVESCO R 58 AMPK activators 58 Endotis 58 protein mTOR 58 nucleoside reverse transcriptase inhibitor 58 PDGFR 58 Vascular Disrupting Agent 58 RLY# 58 investigational compounds 58 Quinamed 58 renin inhibitors 58 4 PDE4 enzyme 58 acetylcholinesterase AChE 58 cyclophosphamide methotrexate 58 glycoprotein GP IIb IIIa 58 HCV polymerase 58 SERMs 58 Rotigotine 58 developing TB4 58 LANTUS ® 58 Anacetrapib 58 Coversyl 58 PTP 1B 58 Budesonide foam crofelemer 58 HDAC Inhibitor 58 catheter occlusion 58 Severe Sepsis 58 Initiates Phase 58 substrates inhibitors 58 pro apoptotic